← All trials
NCT05918640
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 27, 2023
- Primary completion
- Jul 30, 2026
- Completion date
- Jul 30, 2028
- First posted
- Jun 26, 2023
- Last posted
- Dec 14, 2023
- Enrollment
- 56
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of PennsylvaniaLead sponsor
- Jazz PharmaceuticalsCollaborator
- University of PennsylvaniaOverall official - principal investigator
- Stand Up To CancerCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.